Science ❯Biotechnology ❯Drug Development

Clinical Trials

VG-3927 Lung Cancer RSV and Cancer Vaccines GLP-1 Receptor Agonists BNT327 FDA Approvals Therapeutic Innovations Mast Cell Biology Phase I Trials Safety Regulations Regulatory Approval Long-Acting Injectables Weight Loss Mechanisms Animal Health

Trials Start on GLP‑1‑Mimic Implants to Curb Obesity in Dogs

The implants use pet‑tuned GLP‑1 mimics in six‑month subdermal devices with a potential launch window of 2028 to 2029.

Weekly Parkinson’s Injection Secures Patent After Successful Lab Trials

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Sanofi to Acquire Vigil Neuroscience in $600M Deal to Advance Alzheimer’s Research

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial